Holen Sie sich die Stockscreener-App
0.4152
0.19%
-0.0008
Handel nachbörslich:
.42
0.0048
+1.16%
Schlusskurs vom Vortag:
$0.416
Offen:
$0.4225
24-Stunden-Volumen:
2.38M
Relative Volume:
0.13
Marktkapitalisierung:
$27.08M
Einnahmen:
$1.16M
Nettoeinkommen (Verlust:
$-37.28M
KGV:
-0.6388
EPS:
-0.65
Netto-Cashflow:
$-33.81M
1W Leistung:
-0.57%
1M Leistung:
+162.12%
6M Leistung:
+38.68%
1J Leistung:
-71.37%
1-Tages-Spanne:
$0.407
$0.4477
1-Wochen-Bereich:
$0.3733
$0.4477
52-Wochen-Spanne:
$0.1406
$3.5299
Glycomimetics Inc Stock (GLYC) Company Profile
Firmenname
Glycomimetics Inc
Sektor
Branche
Telefon
240-243-1201
Adresse
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Vergleichen Sie GLYC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| GLYC | 0.4152 | 27.08M | 1.16M | -37.28M | -33.81M | -0.65 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-26 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-22 | Eingeleitet | CapitalOne | Overweight |
| 2021-11-12 | Hochstufung | Jefferies | Hold → Buy |
| 2019-11-14 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-08-05 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-12-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-26 | Eingeleitet | SunTrust | Buy |
| 2015-03-17 | Bestätigt | Stifel | Buy |
Alle ansehen
Glycomimetics Inc Aktie (GLYC) Neueste Nachrichten
StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
GlycoMimetics: Q3 Earnings Snapshot - Darien Times
Crescent Biopharma to Showcase Cancer Drug Pipeline at Jefferies Healthcare Conference | GLYC Stock News - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders - The Malaysian Reserve
GlycoMimetics and Crescent Biopharma Update Investor Presentation in Connection with Proposed Merger - Defense World
RA Capital Management's Strategic Acquisition of GlycoMimetics I - GuruFocus.com
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting - BioSpace
GlycoMimetics to Present Major AML Drug Trial Data at ASH 2024 Conference | GLYC Stock News - StockTitan
Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News
GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World
Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement - MSN
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC - WICZ
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders - Marketscreener.com
What Do Wall Street Analysts Think About GlycoMimetics Inc (NASDAQ: GLYC) Stock? - Stocks Register
INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc.GLYC - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders - The Malaysian Reserve
GlycoMimetics’ Acquisition of Crescent Biopharma - Global Legal Chronicle
GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today - MSN
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc.GLYC - Business Wire
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
GlycoMimetics Announces Merger Agreement with Crescent Biopharma: A Look at the Details - Defense World
GlycoMimetics To Acquire Crescent Biopharma - FinSMEs
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm - Morningstar
GlycoMimetics soars on news of M&A deal with Crescent Biopharma - The Pharma Letter
GlycoMimetics Announces Merger with Crescent Biopharma - Yahoo Finance
GlycoMimetics Insider Confidence Rewarded, Stock Hits US$11m Market Cap - Simply Wall St
Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today - Barchart
Biotech Up Over +100% Premarket Following Merger And Funding Announcement - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE – ARC) - ForexTV.com
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results - Benzinga
GlycoMimetics Stock Triples To Become Top Gainer On Crescent Biopharma Merger Deal: Retail Goes Wild - Barchart
GlycoMimetics Shares Are Soaring Tuesday: Here's Why - Benzinga
Crescent Inks Oncology Merger With $200M In Private Funding - Law360
TSX Smallcap Select Index (TXSC) QuotePress Release - The Globe and Mail
GlycoMimetics Agrees to Acquire Crescent Biopharma - MarketWatch
Crescent rolls up to Glycomimetics merger, $200M in new bread - BioWorld Online
Shareholder Alert: Ademi LLP Investigates Whether GlycoMimetics, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE and GLYC on Behalf of Shareholders - Marketscreener.com
TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail
US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga
TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail
Crescent inks GlycoMimetics merger, securing Nasdaq listing and $200M for hot cancer program - Fierce Biotech
GlycoMimetics skyrockets on buyout deal - MSN
Rockville biotech GlycoMimetics to be acquired - The Business Journals
GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders - Business Wire
GlycoMimetics enters acquisition agreement with Crescent Biopharma - TipRanks
GlycoMimetics Agrees to Be Taken Private by Crescent Biopharma - MarketWatch
Glycomimetics Shares Fall After Leukemia Treatment Trial Misses Key Goal - MarketWatch
Finanzdaten der Glycomimetics Inc-Aktie (GLYC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):